Ulcerative colitis
Conditions
Interventions
Experimental Group:Shen Zhu Qing Hua Compound
Sponsors
Nanjing Hospital of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: (1) The patient meets the diagnostic requirements of Western medicine, with the severity of the condition being mild or moderate; (2) The patient satisfies the diagnostic criteria of traditional Chinese medicine, classified as spleen deficiency with dampness accumulation; (3) Age between 18 and 70 years old; (4) The patient is fully aware of all the aforementioned criteria and requirements, participates on a voluntary basis, and has provided informed consent after thorough understanding, signing the informed consent form.
Exclusion criteria
Exclusion criteria: (1) Pregnant women, those preparing for pregnancy, or women in the lactation period; (2) Individuals with allergic constitutions or hypersensitivity to this medication; (3) Patients with severe primary diseases of the liver, kidneys, or hematopoietic system, or patients with mental illness; (4) Patients who have participated in other drug clinical trials within the past 4 weeks; (5) Patients with severe ulcerative colitis (UC).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| TCM Syndrome Score;Modified Mayo Score;C-reactive protein;Erythrocyte Sedimentation Rate;Tumor Necrosis Factor-alpha;Interleukin-6;plasma endotoxin;D-lactic acid;Fecal Calprotectin;Motilin;gastrin;Diamine Oxidase; | — |
Countries
China
Contacts
Public ContactTan Yanyan
Nanjing Hospital of Chinese Medicine
Outcome results
None listed